IMIO develops and manufactures freeze-dried agricultural biologicals that break down post-harvest crop residue to release nutrients back into the soil, improving crop performance, nutrient efficiency and soil function. Its flagship Re-Gen line, offered for row crops and produce, applies a precision biomanufacturing process that grows and tests each microbial strain individually before freeze-drying it for shelf stability. Founded in 2019 and headquartered in Chicago, IMIO serves more than 100 grower customers across the US.
1
Round
1
Industry
4
Tags
Oct 20, 2026
Latest raise
Funding activity · 1 round
Oct 20, 2026
$12M
Seed
Led by Sofinnova Partners
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
